Collateral activity of the CRISPR/RfxCas13d system in human cells
The collateral activity of the CRISPR/RfxCas13d system in mammalian cells is explored using spike-in RNA-seq and reporter assays.
Main Authors: | Peiguo Shi, Michael R. Murphy, Alexis O. Aparicio, Jordan S. Kesner, Zhou Fang, Ziheng Chen, Aditi Trehan, Yang Guo, Xuebing Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-03-01
|
Series: | Communications Biology |
Online Access: | https://doi.org/10.1038/s42003-023-04708-2 |
Similar Items
-
The collateral activity of RfxCas13d can induce lethality in a RfxCas13d knock-in mouse model
by: Yunfei Li, et al.
Published: (2023-02-01) -
Optimized CRISPR-RfxCas13d system for RNA targeting in zebrafish embryos
by: Luis Hernandez-Huertas, et al.
Published: (2022-03-01) -
A Mutated Nme1Cas9 Is a Functional Alternative RNase to Both LwaCas13a and RfxCas13d in the Yeast S. cerevisiae
by: Yadan Zhang, et al.
Published: (2022-06-01) -
RfxCas13d-mediated inhibition of Circ1647 alleviates renal fibrosis via PI3K/AKT signaling pathway
by: Yufang Ni, et al.
Published: (2024-12-01) -
The Bacterial Enzyme RfxCas13d Is Less Neurotoxic Than PspCas13b and Could Be a Promising RNA Editing and Interference Tool in the Nervous System
by: Qin-Wei Wu, et al.
Published: (2021-08-01)